Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01982123 · ClinicalTrials.gov registry record · NA
SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy
A NA study of Malignant Neoplasm and Lung Carcinoma, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 2
- Study locations
NCT01982123 is a NA study of Malignant Neoplasm and Lung Carcinoma that has completed, run by University of Washington. The registered enrollment target is 12 participants, below the 513-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01982123, a NA study of Malignant Neoplasm and Lung Carcinoma, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 2
- Study locations
Study Summary
This pilot clinical trial studies single photon emission computed tomography (SPECT)/computed tomography (CT) in measuring lung function in patients with cancer undergoing radiation therapy. Diagnostic procedures that measure lung function may help doctors find healthy lung tissue and allow them to plan better treatment.
Conditions Studied
Interventions
- PROCEDURE Single Photon Emission Computed Tomography
- DIAGNOSTIC_TEST SPECT/CT
- RADIATION Technetium Tc-99m Albumin Aggregated
- DRUG Technetium Tc-99m DTPA
Study Locations (2)
Washington
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium - Seattle
- ProCure Proton Therapy Center-Seattle - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-01-17 |
| Est. Completion | 2017-09-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01982123
The ClinicalTrials.gov registry entry for NCT01982123 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 513-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (98% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Malignant Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which Single Photon Emission Computed Tomography is the first listed.
NCT01982123 reports 2 study locations spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT01982123 about?
NCT01982123 is a clinical study titled "SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy". This pilot clinical trial studies single photon emission computed tomography (SPECT)/computed tomography (CT) in measuring lung function in patients with cancer undergoing radiation therapy. Diagnostic procedures that measure lung function may help doctors find healthy lung tissue and allow them to ...
What is the current status of trial NCT01982123?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2014-01-17. Estimated completion is 2017-09-13.
What conditions does trial NCT01982123 study?
This clinical trial studies the following conditions: Malignant Neoplasm, Lung Carcinoma.
What interventions are being tested in trial NCT01982123?
The interventions under investigation include: Single Photon Emission Computed Tomography (PROCEDURE), SPECT/CT (DIAGNOSTIC_TEST), Technetium Tc-99m Albumin Aggregated (RADIATION), Technetium Tc-99m DTPA (DRUG).
Who is sponsoring clinical trial NCT01982123?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01982123 being conducted?
This trial has 2 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
RECRUITING · NA
-
Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials
RECRUITING · NA
-
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
RECRUITING · NA
-
Decreasing Chemotherapy Induced Distress Using Immersive Virtual Reality in Patients With Cancer
RECRUITING · NA
-
A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant
RECRUITING · NA
-
Reproductive Health Program in Patients With Cancer
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.